Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Toxoplasma and schizophrenia.

Yolken RH, Dickerson FB, Fuller Torrey E.

Parasite Immunol. 2009 Nov;31(11):706-15. doi: 10.1111/j.1365-3024.2009.01131.x. Review.

2.

[Toxoplasma gondii: a potential role in the genesis of psychiatric disorders].

Fond G, Capdevielle D, Macgregor A, Attal J, Larue A, Brittner M, Ducasse D, Boulenger JP.

Encephale. 2013 Feb;39(1):38-43. doi: 10.1016/j.encep.2012.06.014. Epub 2012 Aug 21. Review. French.

4.

Toxoplasma gondii and schizophrenia.

Torrey EF, Yolken RH.

Emerg Infect Dis. 2003 Nov;9(11):1375-80. Review.

5.

The schizophrenia and Toxoplasma gondii connection: infectious, immune or both?

Tamer GS, Dundar D, Yalug I, Caliskan S, Yazar S, Aker A.

Adv Ther. 2008 Jul;25(7):703-9. doi: 10.1007/s12325-008-0063-5.

PMID:
18563312
6.

Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia.

Yolken RH, Bachmann S, Ruslanova I, Lillehoj E, Ford G, Torrey EF, Schroeder J.

Clin Infect Dis. 2001 Mar 1;32(5):842-4. Epub 2001 Feb 28. Erratum in: Clin Infect Dis 2001 Apr 15;32(8):1247. Rouslanova I [corrected to Ruslanova I].

PMID:
11229859
7.

Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host.

Saeij JP, Boyle JP, Boothroyd JC.

Trends Parasitol. 2005 Oct;21(10):476-81. Review.

PMID:
16098810
8.

Antibodies to infectious agents in individuals with recent onset schizophrenia.

Leweke FM, Gerth CW, Koethe D, Klosterkötter J, Ruslanova I, Krivogorsky B, Torrey EF, Yolken RH.

Eur Arch Psychiatry Clin Neurosci. 2004 Feb;254(1):4-8.

PMID:
14991372
10.

[Study of persistence of low virulent strain of Toxoplasma gondii on in vivo model].

Goncharov DB, Gubarev EV, Tishkevich IM, Kobets NV, Parkhomenko IuG, Borovaia TG, Marakusha BI, Shevliagina NV, Paregudova AB.

Zh Mikrobiol Epidemiol Immunobiol. 2009 Jul-Aug;(4):107-11. Russian.

PMID:
19715214
11.

Neuropsychiatric disease and Toxoplasma gondii infection.

Henriquez SA, Brett R, Alexander J, Pratt J, Roberts CW.

Neuroimmunomodulation. 2009;16(2):122-33. doi: 10.1159/000180267. Epub 2009 Feb 11. Review.

PMID:
19212132
12.

Are some cases of psychosis caused by microbial agents? A review of the evidence.

Yolken RH, Torrey EF.

Mol Psychiatry. 2008 May;13(5):470-9. doi: 10.1038/mp.2008.5. Epub 2008 Feb 12. Review.

PMID:
18268502
13.

Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS.

Grant IH, Gold JW, Rosenblum M, Niedzwiecki D, Armstrong D.

AIDS. 1990 Jun;4(6):519-21.

PMID:
2386617
14.

Evaluation of five antischizophrenic agents against Toxoplasma gondii in human cell cultures.

Goodwin DG, Strobl JS, Lindsay DS.

J Parasitol. 2011 Feb;97(1):148-51. doi: 10.1645/GE-2536.1. Epub 2010 Sep 14.

PMID:
21348624
15.

Genetic approaches to studying virulence and pathogenesis in Toxoplasma gondii.

Sibley LD, Mordue DG, Su C, Robben PM, Howe DK.

Philos Trans R Soc Lond B Biol Sci. 2002 Jan 29;357(1417):81-8.

16.

Toxoplasmosis: comparative species susceptibility and host immune response.

Innes EA.

Comp Immunol Microbiol Infect Dis. 1997 Feb;20(2):131-8. Review.

PMID:
9208198
17.
18.

Seropositivity of toxoplasmosis in patients with schizophrenia.

El-Sahn AA, Shatat HZ, Ghitany EM.

J Egypt Public Health Assoc. 2005;80(5-6):509-24.

PMID:
17187740
19.

Killing of Toxoplasma gondii oocysts by irradiation and protective immunity induced by vaccination with irradiated oocysts.

Dubey JP, Jenkins MC, Thayer DW, Kwok OC, Shen SK.

J Parasitol. 1996 Oct;82(5):724-7.

PMID:
8885879
20.

Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade.

Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M.

Am J Trop Med Hyg. 2007 Sep;77(3):405-10.

PMID:
17827351

Supplemental Content

Support Center